Lipid Clinics Network. Rationale and design of the EAS global project

Atheroscler Suppl. 2020 Dec;42:e6-e8. doi: 10.1016/j.atherosclerosissup.2021.01.002.ABSTRACTThe evidence of the causal role of low-density lipoprotein cholesterol in the development of atherosclerotic cardiovascular disease is well-established. The clearly identified common position of the European guidelines proclaims necessity to decrease LDL-C concentrations based on a proper risk stratification. However, current worldwide situation with the lipid management still demonstrates inadequate dyslipidemia control, that is probably related to a healthcare system issues. As the need to standardize and implement approaches following the guidelines into clinical practice remains a challenge, the EAS initiates the Lipid Clinics Network project, aiming to provide a structure to establish uniform EU-wide standards of diagnosis, management and treatment of patients with lipid disorders, based on the ESC/EAS Guidelines on management of dyslipidaemias.PMID:33589226 | DOI:10.1016/j.atherosclerosissup.2021.01.002

Source: Atherosclerosis Supplements - February 16, 2021 Category: Cardiology Authors: Asiiat S Alieva Lale Tokg özoğlu Kausik K Ray Alberico L Catapano Source Type: research